Skip to content

Research on modulating mechanism of repetitive transcranial magnetic stimulation in subjective cognitive decline: a randomized controlled trial.

Research on modulating mechanism of repetitive transcranial magnetic stimulation in subjective cognitive decline

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034533
Enrollment
Unknown
Registered
2020-07-08
Start date
2020-07-08
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

subjective cognitive decline

Interventions

real rTMS-DLPFC:rTMS
sham rTMS-DLPFC:sham rTMS
real rTMS-precuneus:rTMS
sham rTMS-precuneus:rTMS

Sponsors

Affiliated Brain Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Self-reported persistent memory decline, which was confirmed by an informant; 2. Performance within the normal range on MMSE and MoCA (adjusted for age and education); 3. Clinical Dementia Rating (CDR) = 0; 4. Subjects aged between 50 and 80 years old; 5. Onset is less than 5 years; 6. Subjective Cognitive Decline Questionnaire (SCD-Q) score > 5.

Exclusion criteria

Exclusion criteria: 1. A past history of stroke (modified Hachinski Ischemic Scale Score of > 4), alcoholism, head injury, brain tumors, Parkinson's disease, epilepsy, encephalitis, major depression (excluded by HAMD), or other neurological or psychiatric illness (excluded by clinical assessment and case history); 2. Major medical illness (e.g., cancer, anemia, thyroid dysfunction, syphilis, or HIV); 3. Severe visual or hearing loss; 4. Unable to complete neuropsychological tests or with a contraindication for MRI, and 5. T2-weighted MRI showing major white matter (WM) changes, infarction, or other lesions (two experienced radiologists analyzed the scans).

Design outcomes

Primary

MeasureTime frame
cognition socre;Network functional connectivity;SCD-Q;

Countries

China

Contacts

Public ContactChen Jiu

Affiliated Brain Hospital of Nanjing Medical University

ericcst@aliyun.com+86 025-82296623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026